The majority of reagent monoclonal antibodies available today are generated from hybridomas, or immortal antibody-producing cells created by fusing a tumor cell with an antibody-producing B cell from an immunized animal. However, hybridomas suffer from limitations like batch-to-batch variability as a result of genetic drift and genetic instability that impacts expression. Additionally, more than 30% … Continue reading Tailored Confidence: Recombinant Antibodies for Research